The Clinical Trials Research Unit (CTRU) at the University of Leeds has developed a series of webinars for researchers and clinicians about the UKMRA-Myeloma UK-Concept and Access Research Programme (CARP) and how it supports the development of early phase myeloma clinical trials.

CARP is a research initiative funded by Myeloma UK that focuses on the development of early phase myeloma trials. It also gives early career researchers or clinicians seeking trials experience the opportunity to get advice and develop their skills with the expertise and support of the UK Myeloma Research Alliance and the University of Leeds Clinical Trials Research Unit.

The webinars provide information about why CARP was created, how it can help researchers develop early phase trials and provide details of what is involved in early phase trial design. The speakers are senior trialists and patient representatives who are all actively involved in CARP. Each one-hour session will consist of 30-45 minutes of presentation(s) followed by Q&A.

Upcoming webinars:

Public and patient involvement and engagement in clinical trials

Thursday 24 June, 1-2 pm

Holly Schofield, Public and Patient Involvement and Engagement Lead at Leeds CTRU, will provide an overview of the recently updated policy and guidance for public involvement in research.

Dr Sandra Quinn, Health Services Research Manager at Myeloma UK, will speak about the Myeloma UK Patient and Carer Research Panel and how it supports patient involvement in developing and designing research studies.

A patient representative will share some of their experiences of being involved in research as a public contributor.

Register now on Eventbrite.

Previous webinars:

Developing early phase myeloma research in the UK: an introduction to the UKMRA-MUK-Concept and Access Research Programme

Recorded on 25 March 2021

Prof. Gordon Cook, Clinical Director (Haematology) Clinical Trials Research Unit, provides an overview of early phase myeloma trials in the UK.

Sarah McDonald, Director of Research at Myeloma UK, shares her thoughts on the importance of early phase research.

Dr Sarah Brown, CARP lead, Associate Professor at the University of Leeds Clinical Trials Research Unit, discusses the practicalities of developing an early phase clinical trial proposal through CARP.

Implementation of an early phase myeloma platform trial

Recorded on 29 April 2021

Dr Rakesh Popat, Consultant Haematologist and Honorary Associate Professor at University College London Hospital, shares his experiences of developing and setting up an early phase myeloma clinical trial through CARP.